Fungal Lanosterol 14α-demethylase: A target for next-generation antifungal design BC Monk, AA Sagatova, P Hosseini, YN Ruma, RK Wilson, MV Keniya Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1868 (3), 140206, 2020 | 99 | 2020 |
Identification of bioactive metabolites and evaluation of in vitro anti-inflammatory and in vivo antinociceptive and antiarthritic activities of endophyte fungi isolated from … K Mazumder, YN Ruma, R Akter, A Aktar, MM Hossain, Z Shahina, ... Journal of Ethnopharmacology 273, 113975, 2021 | 20 | 2021 |
Heterologous expression of full-length lanosterol 14α-demethylases of prominent fungal pathogens Candida albicans and Candida glabrata provides tools for antifungal discovery MV Keniya, YN Ruma, JDA Tyndall, BC Monk Antimicrobial agents and chemotherapy 62 (11), 10.1128/aac. 01131-18, 2018 | 18 | 2018 |
Characterisation of Candida parapsilosis CYP51 as a Drug Target Using Saccharomyces cerevisiae as Host YN Ruma, MV Keniya, JDA Tyndall, BC Monk Journal of Fungi 8 (1), 69, 2022 | 14 | 2022 |
Structural Insights into the Azole Resistance of the Candida albicans Darlington Strain Using Saccharomyces cerevisiae Lanosterol 14α-Demethylase as a … DO Graham, RK Wilson, YN Ruma, MV Keniya, JDA Tyndall, BC Monk Journal of Fungi 7 (11), 897, 2021 | 5 | 2021 |
Exploring Cryptococcus neoformans CYP51 and Its Cognate Reductase as a Drug Target YN Ruma, MV Keniya, BC Monk Journal of Fungi 8 (12), 1256, 2022 | 2 | 2022 |
Development of Cryptococcus neoformans and Candida parapsilosis lanosterol 14α-demethylase (CYP51) as drug targets YN Ruma University of Otago, 2021 | 1 | 2021 |
MicroED structure of the C11 cysteine protease Clostripain YN Ruma, G Bu, J Hattne, T Gonen Journal of Structural Biology: X, 100107, 2024 | | 2024 |
Structure of the lens MP20 mediated adhesive junction WJ Nicolas, A Shiriaeva, MW Martynowycz, AC Grey, Y Ruma, ... bioRxiv, 2024 | | 2024 |